AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2023
Nov 16, 2023
30826_dirs_2023-11-16_af1c7458-57bb-4cf8-a2c6-c4fa88cc5a72.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2023-11-14
Reporting Person: Hunt Anthony (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-14 | Common Stock | G | 1000 | $0.00 | Disposed | 194307 | Direct |
Footnotes
F1: The shares were disposed of in connection with a bona fide gift by the Reporting Person to a donor advised fund.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23